Open Access Open Access  Restricted Access Subscription Access

Objectives, Etiology, Epidemiology, Pathophysiology, Diagnosis, Differential Diagnosis, Treatment, Prognosis and Complications of Pyruvate Kinase Deficiency

Muralinath E., Guruprasad M., Madhavi Latha C., Sheethal U., Rajitha V., Manohar U., Srinadh G., Rohitha K.

Abstract


The most prevalent enzyme-related glycolytic deficit that causes red cell hemolysis is pyruvate kinase deficiency (PKD). Hereditary non-spherocytic anemia is always the result of PKD. This exercise explains how to diagnose and treat pyruvate kinase deficiency and emphasizes how the medical staff may help people with this illness.


Full Text:

PDF

References


Salek, S., Boscoe, A. N., Piantedosi, S., Egan, S., Evans, C. J., Wells, T., Cohen, J., Klaassen, R. J., Grace, R., & Storm, M. (2020). Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease-specific assessments. European Journal of Haematology, 104(5), 427–434.

Machado, P., Manco, L., Gomes, C., Mendes, C., Fernandes, N., Salomé, G., Sitoe, L., Chibute, S., Langa, J., Ribeiro, L., Miranda, J., Cano, J., Pinto, J., Amorim, A., do Rosário, V. E., & Arez, A. P. (2012). Pyruvate kinase deficiency in sub-Saharan Africa: Identification of a highly frequent missense mutation (G829A; Glu277Lys) and association with malaria. PLoS ONE, 7(10), e47071. https://doi.org/10.1371/journal.pone.0047071

Cançado, R. D. (2018). Pyruvate kinase deficiency: Novel mutations and a better understanding of the genotype-to-phenotype correlation in Brazilian patients. Hematology, Transfusion and Cell Therapy, 40(1), 1–2.

Bianchi, P., Fermo, E., Glader, B., Kanno, H., Agarwal, A., Barcellini, W., Eber, S., Hoyer, J. D., Kuter, D. J., Maia, T. M., Mañu-Pereira, M. D. M., Kalfa, T. A., Pissard, S., Segovia, J. C., van Beers, E., Gallagher, P. G., Rees, D. C., & van Wijk, R. (2019). Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency. American Journal of Hematology, 94(1), 149–161.

Secrest, M. H., Storm, M., Carrington, C., Casso, D., Gilroy, K., Pladson, L., & Boscoe, A. N. (2020). Prevalence of pyruvate kinase deficiency: A systematic literature review. European Journal of Haematology, 105(2), 173–184.

Svidnicki, M. C. C. M., Santos, A., Fernandez, J. A. A., Yokoyama, A. P. H., Magalhães, I. Q., Pinheiro, V. R. P., Brandalise, S. R., Silveira, P. A. A., Costa, F. F., & Saad, S. T. O. (2018). Novel mutations associated with pyruvate kinase deficiency in Brazil. Hematology, Transfusion and Cell Therapy, 40(1), 5–11.

Jaouani, M., Manco, L., Kalai, M., Chaouch, L., Douzi, K., Silva, A., Macedo, S., Darragi, I., Boudriga, I., Chaouachi, D., Fitouri, Z., van Wijk, R., Ribeiro, M. L., & Abbes, S. (2017). Molecular basis of pyruvate kinase deficiency among Tunisians: Description of new mutations affecting coding and noncoding regions in the PKLR gene. International Journal of Laboratory Hematology, 39(2), 223–231.

Radošinská, J., & Vrbjar, N. (2016). The role of red blood cell deformability and Na,K-ATPase function in selected risk factors of cardiovascular diseases in humans. Physiological Research, 65(Suppl 1), S43–S54.

Grace, R. F., Zanella, A., Neufeld, E. J., Morton, D. H., Eber, S., Yaish, H., & Glader, B. (2015). Erythrocyte pyruvate kinase deficiency: 2015 status report. American Journal of Hematology, 90(9), 825–830.

Chartier, M. E., Hart, L., Paganelli, M., Ahmed, N., Bilodeau, M., & Alvarez, F. (2018). Successful liver transplants for liver failure associated with pyruvate kinase deficiency. Pediatrics, 141(Suppl 5), S385–S389.

Yamada, M., & Sakai, H. (2017). Hidden antioxidative functions of reduced nicotinamide adenine dinucleotide coexisting with hemoglobin. ACS Chemical Biology, 12(7), 1820–1829.

Bagla, S., Bhambhani, K., Gadgeel, M., Buck, S., Jin, J.-P., & Ravindranath, Y. (2019). Compound heterozygosity in PKLR gene as a novel cause of severe pyruvate kinase deficiency. Haematologica, 104(9), e428–e431.

Grace, R. F., Layton, D. M., & Barcellini, W. (2019). How we manage patients with pyruvate kinase deficiency. British Journal of Haematology, 184(5), 721–734.

Lesmana, H., Dyer, L., Li, X., Denton, J., Griffiths, J., Chonat, S., Seu, K. G., Heeney, M. M., Zhang, K., Hopkin, R. J., & Kalfa, T. A. (2018). Alu element insertion in PKLR gene as a novel cause of pyruvate kinase deficiency. Human Mutation, 39(3), 389–393.

Klei, T. R. L., Kheradmand Kia, S., Veldthuis, M., Beuger, B. M., Geissler, J., Dehbozorgian, J., Karimi, M., van Bruggen, R., & van Zwieten, R. (2017). Residual pyruvate kinase activity in PKLR-deficient erythroid precursors. European Journal of Haematology, 98(6), 584–589.

Steiner, L. A., & Gallagher, P. G. (2007). Erythrocyte disorders in the perinatal period. Seminars in Perinatology, 31(4), 254–261.

Christensen, R. D., Eggert, L. D., Baer, V. L., & Smith, K. N. (2010). Pyruvate kinase deficiency as a cause of extreme hyperbilirubinemia in neonates. Journal of Perinatology, 30(3), 233–236.

Nassin, M. L., Lapping-Carr, G., & de Jong, J. L. (2015). Anemia in the neonate: The differential diagnosis and treatment. Pediatric Annals, 44(7), e159–e163.

Meza, N. W., Alonso-Ferrero, M. E., Navarro, S., Quintana-Bustamante, O., Valeri, A., Garcia-Gomez, M., Bueren, J. A., Bautista, J. M., & Segovia, J. C. (2009). Rescue of pyruvate kinase deficiency in mice by gene therapy. Molecular Therapy, 17(12), 2000–2009.

Christensen, R. D., Yaish, H. M., Nussenzveig, R. H., & Agarwal, A. M. (2016). Siblings with severe pyruvate kinase deficiency and a complex genotype. American Journal of Medical Genetics Part A, 170(9), 2449–2452.

Chandra, S., Tripathi, A. K., Mishra, S., Amzarul, M., & Vaish, A. K. (2012). Physiological changes in hematological parameters during pregnancy. Indian Journal of Hematology and Blood Transfusion, 28(3), 144–146.

Vricella, L. K. (2017). Emerging understanding and measurement of plasma volume expansion in pregnancy. American Journal of Clinical Nutrition, 106(Suppl 6), 1620S–1625S.

Haley, K. (2017). Congenital hemolytic anemia. Medical Clinics of North America, 101(2), 361–374.

An, X., Wang, J., Zhuang, X., Dai, J., Lu, C., Li, X., & Yan, Y. (2015). Clinical features of neonates with hydrops fetalis. American Journal of Perinatology, 32(13), 1231–1239.

van Beers, E. J., van Straaten, S., Morton, D. H., Barcellini, W., Eber, S. W., Glader, B., Yaish, H. M., Chonat, S., Kwiatkowski, J. L., Rothman, J. A., et al. (2019). Prevalence and management of iron overload in pyruvate kinase deficiency. Haematologica, 104(2), e51–e53.

Jones, A. D., Khan, M., Cheshire, J., & Bowley, D. (2016). Postsplenectomy prophylaxis: A persistent failure to meet standard? Open Forum Infectious Diseases, 3(4), ofw197.

Dolan, L. M., Ryan, M., & Moohan, J. (2002). Pyruvate kinase deficiency in pregnancy complicated by iron overload. BJOG: An International Journal of Obstetrics & Gynaecology, 109(7), 844–846.

Mohamed, S., Sivarajah, K., & Chakravarti, S. (2013). A case of severe pyruvate kinase deficiency in a primigravida. Obstetric Medicine, 6(2), 90–91.

Iolascon, A., Avvisati, R. A., & Piscopo, C. (2010). Hereditary spherocytosis. Transfusion Clinique et Biologique, 17(3), 138–142.

Bubp, J., Jen, M., & Matuszewski, K. (2015). Caring for glucose-6-phosphate dehydrogenase–deficient patients. P & T, 40(9), 572–574.

Satyagraha, A. W., Sadhewa, A., Elvira, R., Elyazar, I., Feriandika, D., Antonjaya, U., et al. (2016). Assessment of point-of-care diagnostics for G6PD deficiency in malaria endemic rural eastern Indonesia. PLoS Neglected Tropical Diseases, 10(2), e0004457. https://doi.org/10.1371/journal.pntd.0004457

Shaikh, H., Bakalov, V., Shaikh, S., & Amjad, A. (2019). Paravertebral mass and diffuse lymphadenopathy in a patient with pyruvate kinase deficiency. Cureus, 11(6), e4849.


Refbacks

  • There are currently no refbacks.